194
Participants
Start Date
May 1, 2017
Primary Completion Date
April 30, 2021
Study Completion Date
July 31, 2023
Efficacy of albendazole for early stage intervention of alveolar echinococcosis
Participants in the treatment arm will be treated with albendazole, 2 x 400 mg daily for the duration of the study. Treatment may be prolonged beyond the end of the study if clinically appropriate.
Department of disease prevention and sanitary - epidemiological surveillance, Bishkek
University of Zurich
OTHER
Ministry of Health, Kyrgyzstan
OTHER_GOV